| Authors: |
Moore S; University Hospitals Bristol & Weston, Bristol, UK., Miller H; The Christie NHS Foundation Trust, Manchester, UK., Parrish C; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Seymour F; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Miller L; Nottingham University Hospitals NHS Trust, Nottingham, UK., Chandler T; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Land J; University College London Hospitals NHS Foundation Trust, London, UK., Karpha I; The Clatterbridge Cancer Centre NHS Trust, Liverpool, UK., Brearton G; The Clatterbridge Cancer Centre NHS Trust, Liverpool, UK., Thompson S; UKMRA Frailty Group, UKMRA patient representative, UK., Clayton L; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Jones J; Brighton and Sussex Medical School, University of Sussex, Brighton, UK.; Kings College Hospital, London, UK., McMillan A; University College London Hospitals NHS Foundation Trust, London, UK.; Whittington Health NHS Trust, London, UK., McCourt O; University College London Hospitals NHS Foundation Trust, London, UK.; Research Department of Haematology, University College London Cancer Institute, London, UK., Pawlyn C; Institute for Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Mian H; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Cook G; Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK. |
